Strength
400 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006022761
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/6/2026
Active Ingredients
RALTEGRAVIR POTASSIUMApproval Type
New Drug (NDA)
FDA Application
NDA022145On Market Since
10/12/2007
Pharmacological Classes
HIV Integrase Inhibitors
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TIVICAY 50 MG TABLET
Brand
49702022813•ViiV Healthcare Company
$77.6627
per EA
DOVATO 50-300 MG TABLET
Brand
49702024613•ViiV Healthcare Company
$105.2874
per EA
DOVATO 50-300 MG TABLET
Brand
49702024633•ViiV Healthcare Company
$105.2874
per EA
JULUCA 50-25 MG TABLET
Brand
49702024213•ViiV Healthcare Company
$121.9492
per EA
TRIUMEQ 600-50-300 MG TABLET
Brand
49702023113•ViiV Healthcare Company
$130.0048
per EA
GENVOYA TABLET
Brand
61958190101•Gilead Sciences, Inc.
$143.3501
per EA
STRIBILD TABLET
Brand
61958120101•Gilead Sciences, Inc.
$150.4090
per EA